Free Trial

Atyr PHARMA (ATYR) Earnings Date, Estimates & Call Transcripts

Atyr PHARMA logo
$3.29 -0.05 (-1.50%)
As of 05/9/2025 03:58 PM Eastern

Atyr PHARMA Earnings Summary

Atyr PHARMA posted Q1 2025 earnings on May 7, 2025, reporting an EPS of -$0.17, which beat analysts' consensus estimates of -$0.19 by $0.02. With a trailing EPS of -$0.81, Atyr PHARMA's earnings are expected to grow next year, from ($0.91) to ($0.87) per share.

Latest Q1
Earnings Date
May. 7Estimated
Consensus EPS
(May. 7)
-$0.19
Actual EPS
(May. 7)
-$0.17 Beat By $0.02
Get Atyr PHARMA Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atyr PHARMA and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ATYR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATYR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Atyr PHARMA Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.21-$0.21-$0.21
Q2 20251-$0.17-$0.17-$0.17
Q3 20252-$0.19-$0.04-$0.12
Q4 20251-$0.17-$0.17-$0.17

Atyr PHARMA Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025-$0.19-$0.17+$0.02-$0.17--
3/13/2025Q4 2024-$0.23-$0.18+$0.05-$0.18$0.02M-
11/7/2024--$0.22-$0.23 -$0.01-$0.23$0.13M-
8/13/2024Q2 2024-$0.24-$0.23+$0.01-$0.23$0.12M-
5/2/2024Q1 2024-$0.24-$0.23+$0.01-$0.23$0.11M$0.24M
3/14/2024Q4 2023-$0.23-$0.25 -$0.02-$0.25--
11/9/2023Q3 2023-$0.21-$0.20+$0.01-$0.20$6.00M$0.35M
8/9/2023Q2 2023-$0.27-$0.22+$0.05-$0.22--

Atyr PHARMA Earnings - Frequently Asked Questions

Atyr PHARMA (NASDAQ:ATYR) last announced its quarterly earning data on Wednesday, May 7, 2025. Learn more on ATYR's earnings history.

In the previous quarter, Atyr PHARMA (NASDAQ:ATYR) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.02. Learn more on analysts' earnings estimate vs. ATYR's actual earnings.

Atyr PHARMA (NASDAQ:ATYR) has a recorded annual revenue of $235,000.00.

Atyr PHARMA (NASDAQ:ATYR) has a recorded net income of -$50.39 million. ATYR has generated -$0.81 earnings per share over the last four quarters.

Atyr PHARMA's earnings are expected to grow from ($0.91) per share to ($0.87) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ATYR) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners